A key attribute of synthetic biomaterials is their ability to mimic naturally occurring biological molecules and systems. The challenge, however, is to generate...

A number of pathogenic bacteria reproduce inside mammalian cells and are thus inaccessible to many antimicrobial drugs. In work published in ACS Infectious Diseases, researchers in the Chmielewski Group...

Liquid-like droplets of biomacromolecules are emerging as a fundamental mechanism of cellular signaling, but designing synthetic mimics to form such...

There is significant current interest in identifying new combination therapies that synergize to treat disease, and it is becoming increasingly...

Ribosomally synthesized and post-translationally modified peptides, RiPPs, are ubiquitous natural products. Bioactive RiPPs are produced from a precursor...

Somatostatin, SS, is a cyclic tetradecapeptide able to inhibit the release of growth hormone, GH, mainly through the binding to two G‐protein coupled...